CardioVascular and Interventional Radiology最新文献_第7页

Robotic-Assisted Endovascular Treatment for Transplant Renal Artery Stenosis: A Feasibility Study. 移植肾动脉狭窄的机器人辅助血管内治疗：可行性研究。

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-06-18 DOI: 10.1007/s00270-024-03780-3

Bruno Pagnin Schmid, Nelson Wolosker, Marcela Juliano Silva Cunha, Leonardo Guedes Moreira Valle, Francisco Leonardo Galastri, Breno Boueri Affonso, Felipe Nasser

引用次数: 0

Percutaneous Endovascular Creation of a Neo-arteriovenous Fistula in Dysfunctional Hemodialysis Fistulas. 在功能失调的血液透析瘘中经皮血管内创建新动静脉瘘。

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-07-15 DOI: 10.1007/s00270-024-03804-y

Huei-Lung Liang, Ming-Feng Li, Chia-Ling Chiang

{"title":"Percutaneous Endovascular Creation of a Neo-arteriovenous Fistula in Dysfunctional Hemodialysis Fistulas.","authors":"Huei-Lung Liang, Ming-Feng Li, Chia-Ling Chiang","doi":"10.1007/s00270-024-03804-y","DOIUrl":"10.1007/s00270-024-03804-y","url":null,"abstract":"Purpose: Arteriovenous fistulas (AVF) is the preferred type of hemodialysis access, but when an arteriovenous anastomosis (AVA) calcifies, surgical revision of the AVF may be required. We report a technique to create percutaneous artery-to-vein intervascular neo-fistulas for re-anastomosis of AVA and evaluate its safety and efficacy.Materials and methods: 9 patients who failed either guidewire navigation or conventional balloon dilation for calcified AVA stenosis/occlusion underwent a salvage procedure of their dialysis shunt by the percutaneous creation of a new arteriovenous fistula. Needle puncture of the adjacent supplying artery and outflow vein under ultrasonographic and/or fluoroscopic guidance was performed and followed by balloon dilation, with or without stent graft placement. The detailed techniques, technical success, primary neo-fistula patency, primary and secondary access patency rates were reported herein.Results: Technical success was achieved in 100% of the 9 patients treated (7 neo-fistulas with stents and 2 neo-fistulas without stent placement). The median primary neo-fistula and access patencies were 15 and 5 months, respectively. The primary neo-fistula patency rates at 6, 12, and 18 months were 72.9%, 54.7% and 27.9%, respectively, with secondary neo-fistula and access patency rates of 72.9%, 72.9% and 72.9%, respectively. One delayed complication of pseudoaneurysm formation occurred, which was managed by the successful endovascular deployment of a stent graft on an out-patient basis.Conclusion: Percutaneous artery-to-vein intervascular neo-fistula creation is feasible for re-anastomosing calcified AVA, with low adverse effects and acceptable primary neo-fistula and secondary access patency.","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Another Piece of the Puzzle-Sirolimus-coated Balloon for Chronic Limb-Threatening Ischemia. 另一块拼图--治疗慢性肢体缺血的西罗莫司涂层球囊。

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-07-24 DOI: 10.1007/s00270-024-03818-6

Ulf Teichgräber

引用次数: 0

Commentary on Percutaneous Biliary Interventions via the Modified Hutson Loop in Patients with Biliary-Enteric Anastomoses: A Retrospective Study. 通过改良 Hutson 环路对胆肠吻合患者进行经皮胆道介入治疗的评论：回顾性研究。

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-07-26 DOI: 10.1007/s00270-024-03817-7

Alaaeldin Ginawi, Salil Karkhanis

引用次数: 0

Safety and Effectiveness of Irreversible Electroporation in Lymph Node Metastases. 淋巴结转移中不可逆电穿孔的安全性和有效性

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-06-28 DOI: 10.1007/s00270-024-03795-w

Govindarajan Narayanan, Ashwin M Mahendra, Nicole T Gentile, Brian J Schiro, Ripal T Gandhi, Constantino S Peña, Madelon Dijkstra

{"title":"Safety and Effectiveness of Irreversible Electroporation in Lymph Node Metastases.","authors":"Govindarajan Narayanan, Ashwin M Mahendra, Nicole T Gentile, Brian J Schiro, Ripal T Gandhi, Constantino S Peña, Madelon Dijkstra","doi":"10.1007/s00270-024-03795-w","DOIUrl":"10.1007/s00270-024-03795-w","url":null,"abstract":"Purpose: Demonstrating the safety and efficacy of percutaneous irreversible electroporation (IRE) for the treatment of lymph node metastases.Materials and methods: An IRB-approved, single-center retrospective review was performed on patients with lymph node metastases gastrointestinal, and genitourinary primary cancers. Primary objective safety was evaluated by assessing complications graded according to the Clavien-Dindo Classification, and efficacy was determined by tumor response on follow-up imaging and local progression-free survival (LPFS). Secondary outcome measures were technical success (complete ablation with an adequate ablative margin > 5 mm), length of hospital stay and distant progression-free survival (DPFS).Results: Nineteen patients underwent percutaneous IRE between June 2018 and February 2023 for lymph node metastases, close to critical structures, such as vasculature, bowel, or nerves. The technical success was achieved in all cases. Complications occurred in four patients (21.1%), including two self-limiting grade 1 hematomas, a grade 1 abdominal pain, and grade 2 nerve pain treated with medication. Seventeen patients were hospitalized overnight, one patient stayed two nights and another patient stayed fourteen nights. Median follow-up was 25.5 months. Median time to local progression was 24.1 months (95% CI: 0-52.8) with 1-, 2-, and 5-year LPFS of 57.9%, 57.9% and 20.7%, respectively. Median time to distant progression was 4.3 months (95% CI: 0.3-8.3) with 1-, 2-, and 5-year DPFS of 31.6%, 13.2% and 13.2%, respectively.Conclusion: IRE is a safe and effective minimally-invasive treatment for lymph node metastases in locations, where temperature dependent ablation may be contraindicated. Care should be taken when employing IRE near nerves.","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Long-Term Outcomes of Balloon TACE for HCC: An European Multicentre Single-Arm Retrospective Study. 球囊 TACE 治疗 HCC 的长期疗效：欧洲多中心单臂回顾性研究。

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-07-02 DOI: 10.1007/s00270-024-03779-w

Pierleone Lucatelli, Bianca Rocco, Thierry De Beare, Gontran Verset, Fabio Fucilli, Elio Damato, Alexandro Paccapelo, Lorenzo Braccischi, Makoto Taninokuchi Tomassoni, Ana-Maria Bucalau, Carlo Catalano, Cristina Mosconi

{"title":"Long-Term Outcomes of Balloon TACE for HCC: An European Multicentre Single-Arm Retrospective Study.","authors":"Pierleone Lucatelli, Bianca Rocco, Thierry De Beare, Gontran Verset, Fabio Fucilli, Elio Damato, Alexandro Paccapelo, Lorenzo Braccischi, Makoto Taninokuchi Tomassoni, Ana-Maria Bucalau, Carlo Catalano, Cristina Mosconi","doi":"10.1007/s00270-024-03779-w","DOIUrl":"10.1007/s00270-024-03779-w","url":null,"abstract":"Purpose: To report response rates (using mRECIST), overall survival (OS), progression-free survival and local tumour recurrence-free survival (LRFS) of balloon-occluded transarterial chemoembolisation (bTACE) for hepatocellular carcinoma (HCC).Materials and methods: Patients from five European centres treated with conventional or drug-eluting microsphere bTACE for HCC were included, and patients already lost to follow-up before 12 months were excluded. Possible factors contributing to LRFS and OS were evaluated with Cox proportional hazards models.Results: Seventy-three patients were enrolled. The mean number of nodules per patient was 2.07(± 1.68), and the average maximum diameter of the nodules was 37 ± 19.9 mm. The response of the target lesion at 6 months was complete response (CR) in 58.9%, partial response (PR) in 28.8%, stable disease (SD) in 6.8% and progressive disease (PD) in 5.5%. The median follow-up time was 31 months; at the last follow-up, target tumour response was CR in 49.3%, PR in 12.3%, SD in 5.5% and PD 32.9%. Overall response at the last follow-up was CR in 17.8%, PR in 9.6%, SD 2.7% and PD in 69.9% (for new lesions in 37% of patients). Median OS was not reached; mean overall survival was 50.0 months, while median LRFS was 31.0 months. At uni- and multivariable analysis, only tumour maximum diameter was related to LRFS (hazard ratio [HR] = 1.021; 95% CI 1.004-1.038, P = 0.015).Conclusions: bTACE demonstrated high efficacy for HCC, with a complete response in 58.9% of patients, a median local recurrence-free survival of 31.0 months and a mean overall survival of 50.0 months.","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141490999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Ties That Bind: Mentorship Against Burnout. 纽带相连：防止职业倦怠的导师制

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-06-06 DOI: 10.1007/s00270-024-03771-4

Anna Alguersuari Cabiscol, Sara Lojo-Lendoiro

引用次数: 0

Multi-Center Two-Year Patency Outcomes of Endovascular Arteriovenous Fistulas (endoAVF) Created with a 4 French System. 使用 4 French 系统创建的血管内动静脉瘘（endoAVF）的多中心两年期通畅率结果。

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-06-05 DOI: 10.1007/s00270-024-03754-5

Erez Klein, Brandon Repko, Alejandro Alvarez, Nicholas Inston, Robert Jones, Dheeraj K Rajan

{"title":"Multi-Center Two-Year Patency Outcomes of Endovascular Arteriovenous Fistulas (endoAVF) Created with a 4 French System.","authors":"Erez Klein, Brandon Repko, Alejandro Alvarez, Nicholas Inston, Robert Jones, Dheeraj K Rajan","doi":"10.1007/s00270-024-03754-5","DOIUrl":"10.1007/s00270-024-03754-5","url":null,"abstract":"Purpose: To assess multicenter two-year patency outcomes of endovascular arteriovenous fistulas (endoAVF) created with the WavelinQ device.Materials and methods: Patients who had fistulas created at three centers from January 2018 to December 2020 were included in this retrospective study. In total, 112 patients underwent endoAVF creation [40 females, 72 males; mean age 60 years (range 18-88)]. Data collected included patient demographics, location of fistula creation, interventions performed, and brachial artery flows pre- and post-creation. Two-year cumulative patency, functional patency, and primary patency were assessed with Kaplan-Meier methodology. Factors affecting patency and maturation were examined using the Cox proportional hazards model.Results: Technical success defined as angiographically successful endoAVF creation was 97.3% (109/112). In 11 patients the fistula did not mature for dialysis use. For 98 patients (87%) with endoAVF maturation, 12- and 24-month cumulative patency was 94.3% and 91.7%. Functional patency (two-needle cannulation) at 12 and 24 months was 95.7% and 92.7%, respectively. Median maturation time is 95 days (IQR 51-231 days). Male gender and brachial vein coiling at the time of endoAVF creation were predictive of maturation. There were 34 censored events (four patients undergoing renal transplantation; 30 patients deceased). Number of reinterventions per patient year was 0.73 where 43 were maturation procedures and 101 were maintenance procedures. One Grade 3 complication occurred of arterial access puncture site pseudoaneurysm.Conclusion: A high two-year functional and cumulative patency following endoAVF creation with the WavelinQ device was observed in this multicenter real-world experience Level of Evidence: 3 Level of Evidence III.","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":null,"pages":null},"PeriodicalIF":2.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141261216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

CIRSE Standards of Practice on Portal Vein Embolization and Double Vein Embolization/Liver Venous Deprivation. CIRSE 门静脉栓塞和双静脉栓塞/肝静脉剥夺实践标准。

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-06-17 DOI: 10.1007/s00270-024-03743-8

Tiago Bilhim, Georg Böning, Boris Guiu, José Hugo Luz, Alban Denys

引用次数: 0

Sustained Effectiveness of Transcatheter Arterial Microembolization for Refractory Ischiogluteal Bursitis. 经导管动脉微栓塞治疗难治性峡部滑囊炎的持续疗效

IF 2.8 3区医学

CardioVascular and Interventional Radiology Pub Date : 2024-08-01 Epub Date: 2024-06-14 DOI: 10.1007/s00270-024-03744-7

Hsuan-Yin Lin, Ya-Chu Shih, Jyh-Wen Chai

引用次数: 0